SecFilingDex

Avalyn Pharma Inc.

27 SEC EDGAR filings indexed (CIK 0001540171) across 7 form types.

Filing profile

Avalyn Pharma Inc. (AVLN) has 27 SEC filings indexed on SecFilingDex, across 7 form types, from April 8, 2026 to August 12, 2026. The filer is classified under Pharmaceutical Preparations (SIC 2834).

Its most frequent disclosure is the Form 4 (Insider transaction) with 8 filings — Statement of changes in beneficial ownership filed by company officers, directors, and 10%+ owners. 27 of these filings were disclosed in the twelve months to August 12, 2026. 2 of the 27 are amendments (a corrected or updated version of an earlier filing).

Disclosure mix

  • 8Form 4Insider transaction · within 2 business days of transaction
  • 8Form 3Initial insider ownership · within 10 days of becoming an insider
  • 58-KMaterial event · event-driven
  • 210-QQuarterly report · quarterly
  • 2S-1/AIPO registration · event-driven (pre-ipo)
  • 1424B4Final prospectus · event-driven
  • 1S-1IPO registration · event-driven (pre-ipo)

Profile derived from 27 indexed filings; every figure traces to the filing records above, each linking back to its original SEC EDGAR document. Filing counts reflect SecFilingDex's current index, not the filer's complete EDGAR history.

All filings

Authoritative source

https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1540171&type=&dateb=&owner=include&count=40

SecFilingDex republishes EDGAR data with provenance. EDGAR is authoritative; this page reflects the most recent index pull.

Disclaimer: SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page is investment, legal, or tax advice.